A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Chee Wah TanProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeWan Ni ChiaProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeXijian QinPei LiuMark ChenNational Centre for Infectious Diseases, Singapore, SingaporeCharles Kevin TiuProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeZhiliang HuCenter for Global Health, School of Public Health, Nanjing Medical University, Nanjing, ChinaVivian Chih-Wei ChenProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeBarnaby Edward YoungDuke-NUS Medical School, Tan Tock Seng Hospital, Singapore, SingaporeWan Rong SiaProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeYee‐Joo TanDepartment of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore, SingaporeRandy FooProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, SingaporeYongxiang YiNanjing Infectious Disease Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, ChinaDavid Chien LyeDuke-NUS Medical School, Tan Tock Seng Hospital, Singapore, SingaporeDanielle E. AndersonProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. [email protected]Lin‐Fa WangProgramme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. [email protected]
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0